Valeant Pharma (VRX) Tops Q4 EPS by 5c; Guides In-Line

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. FIS
3. ARM
4. BROS
5. QCOM
6. EXPE
7. FSLY
8. CPAY
9. FICO
10. PAYC

Go back to Valeant Pharma (VRX) Tops Q4 EPS by 5c; Guides In-Line

Valeant Pharmaceuticals (VRX) PT Lowered to $18 at Jefferies

March 1, 2017 7:46 AM EST

Jefferies lowered its price target on Valeant Pharmaceuticals (NYSE: VRX) to $18.00 (from $22.00) while maintaining a Buy rating following Q4 result and outlook.

Analyst David Steinberg commented, "Q4 EPS of $1.26 was ~5% ahead of cons with revs just topping guidance ($2.28-2.38B) at $2.40B. More importantly,... More